Korean Circ J.  2013 May;43(5):316-328. 10.4070/kcj.2013.43.5.316.

Comparison of Cardiovascular Risk Factors for Peripheral Artery Disease and Coronary Artery Disease in the Korean Population

• Jang SY
• Ju EY
• Cho SI
• Lee SW
• Kim DK

• KMID: 2224925
• DOI: http://doi.org/10.4070/kcj.2013.43.5.316

Abstract

BACKGROUND AND OBJECTIVES
The objective of this study was to analyze and compare risk factors for peripheral artery disease (PAD) and coronary artery disease (CAD).
SUBJECTS AND METHODS
The sample included 7936 Korean patients aged > or =20 years who were hospitalized from 1994 to 2004. Of the 7936 subjects, PAD (n=415), CAD (n=3686), and normal controls (Control) (n=3835) were examined at the Health Promotion Center, Samsung Medical Center.
RESULTS
The mean age (years) of PAD subjects was 64.4 (+/-9.3), while CAD subjects was 61.2 (+/-9.9), and Control subjects was 59.9 (+/-9.1) (p<0.01). The proportion of males was 90.6% for PAD, 71.4% for CAD, and 75.5% for Control subjects (p<0.01). The adjusted odds ratios (ORs) for hypertension, diabetes mellitus, hypercholesterolemia, smoking, metabolic syndrome and chronic kidney disease were significantly higher in subjects with PAD or CAD compared to those in Control. However, the ORs for high density lipoprotein, being overweight, and being obese were significantly lower in PAD subjects compared to those in Control.
CONCLUSION
We found that cardiovascular risk factors were in fact risk factors for both PAD and CAD.

Keyword

Peripheral artery disease; Coronary artery disease; Risk factors

MeSH Terms

Aged
Coronary Artery Disease
Coronary Vessels
Diabetes Mellitus
Electrolytes
Health Promotion
Humans
Hypercholesterolemia
Hypertension
Lipoproteins
Male
Odds Ratio
Overweight
Peripheral Arterial Disease
Renal Insufficiency, Chronic
Risk Factors
Smoke
Smoking
Electrolytes
Lipoproteins
Smoke

Reference

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285:2486–2497.

2. Gornik HL, Creager MA. Contemporary management of peripheral arterial disease: I. Cardiovascular risk-factor modification. Cleve Clin J Med. 2006; 73:Suppl 4. S30–S37.

3. Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J. 1999; 20:344–353.

4. Gorter PM, Olijhoek JK, van der Graaf Y, Algra A, Rabelink TJ, Visseren FL. SMART Study Group. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis. 2004; 173:363–369.

5. Kon V, Linton MF, Fazio S. Atherosclerosis in chronic kidney disease: the role of macrophages. Nat Rev Nephrol. 2011; 7:45–54.

6. Heuser RR. Treatment of lower extremity vascular disease: the Diamondback 360 degrees Orbital Atherectomy System. Expert Rev Med Devices. 2008; 5:279–286.

7. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999; 100:1481–1492.

8. Haltmayer M, Mueller T, Horvath W, Luft C, Poelz W, Haidinger D. Impact of atherosclerotic risk factors on the anatomical distribution of peripheral arterial disease. Int Angiol. 2001; 20:200–207.

9. Hozawa A, Okamura T, Murakami Y, et al. Joint impact of smoking and hypertension on cardiovascular disease and all-cause mortality in Japan: NIPPON DATA80, a 19-year follow-up. Hypertens Res. 2007; 30:1169–1175.

10. Eckel RH, Wassef M, Chait A, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation. 2002; 105:e138–e143.

11. Hatmi ZN, Mahdavi-Mazdeh M, Hashemi-Nazari SS, Hajighasemi E, Nozari B, Mahdavi A. Trend of lipid ratios associated with well known risk factors of coronary artery disease in different age: a population based study of 31,999 healthy individuals. Int J Cardiol. 2011; 151:328–332.

12. Higashiyama A, Okamura T, Ono Y, Watanabe M, Kokubo Y, Okayama A. Risk of smoking and metabolic syndrome for incidence of cardiovascular disease--comparison of relative contribution in urban Japanese population: the Suita study. Circ J. 2009; 73:2258–2263.

13. Kokubo Y, Nakamura S, Okamura T, et al. Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study. Stroke. 2009; 40:2674–2679.

14. Bennett PC, Silverman S, Gill P. Hypertension and peripheral arterial disease. J Hum Hypertens. 2009; 23:213–215.

15. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003; 26:3333–3341.

16. Pasternak RC, Criqui MH, Benjamin EJ, et al. Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. Circulation. 2004; 109:2605–2612.

17. Willigendael EM, Teijink JA, Bartelink ML, et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg. 2004; 40:1158–1165.

18. Tamura U, Tanaka T, Okamura T, et al. Changes in Weight, cardiovascular risk factors and estimated risk of coronary heart disease following smoking cessation in Japanese male workers: HIPOP-OHP study. J Atheroscler Thromb. 2010; 17:12–20.

19. Hwang YC, Jee JH, Oh EY, et al. Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans. Int J Cardiol. 2009; 134:313–321.

20. Carroll MD, Lacher DA, Sorlie PD, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005; 294:1773–1781.

21. Kim S, Popkin BM. Commentary: understanding the epidemiology of overweight and obesity--a real global public health concern. Int J Epidemiol. 2006; 35:60–67. discussion 81-2.

22. Bogers RP, Bemelmans WJ, Hoogenveen RT, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007; 167:1720–1728.

23. Barba R, Bisbe J, Pedrajas JN, et al. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry. Eur J Cardiovasc Prev Rehabil. 2009; 16:457–463.

24. Steinberg BA, Cannon CP, Hernandez AF, Pan W, Peterson ED, Fonarow GC. Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database. Am J Cardiol. 2007; 100:1331–1335.

25. Diehm N, Shang A, Silvestro A, et al. Association of cardiovascular risk factors with pattern of lower limb atherosclerosis in 2659 patients undergoing angioplasty. Eur J Vasc Endovasc Surg. 2006; 31:59–63.

26. Brevetti G, Oliva G, Di Giacomo S, Bucur R, Annecchini R, Di Iorio A. Intermittent claudication in older patients: risk factors, cardiovascular comorbidity, and severity of peripheral arterial disease. J Am Geriatr Soc. 2001; 49:1261–1262.

27. Ness J, Aronow WS, Newkirk E, McDanel D. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic. J Gerontol A Biol Sci Med Sci. 2005; 60:255–257.

28. Ozkan U, Oguzkurt L, Tercan F. Atherosclerotic risk factors and segmental distribution in symptomatic peripheral artery disease. J Vasc Interv Radiol. 2009; 20:437–441.

29. Aboyans V, Criqui MH, Denenberg JO, Knoke JD, Ridker PM, Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation. 2006; 113:2623–2629.

30. Criqui MH, Browner D, Fronek A, et al. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease. An analysis of risk factors. Am J Epidemiol. 1989; 129:1110–1119.